| 注册
首页|期刊导航|中国临床药理学杂志|奥扎格雷钠注射液联合亚低温治疗颅脑外伤急性脑梗死的临床研究

奥扎格雷钠注射液联合亚低温治疗颅脑外伤急性脑梗死的临床研究

陈松芳 邹明 何志勇 胡蓓蕾 郭献阳 盛汉松

中国临床药理学杂志2018,Vol.34Issue(3):206-208,3.
中国临床药理学杂志2018,Vol.34Issue(3):206-208,3.DOI:10.13699/j.cnki.1001-6821.2018.03.004

奥扎格雷钠注射液联合亚低温治疗颅脑外伤急性脑梗死的临床研究

Clinical trial of ozagrel sodium injection combined with mild hypothermia in the treatment of craniocerebral injury acute cerebral infarction

陈松芳 1邹明 1何志勇 1胡蓓蕾 1郭献阳 2盛汉松3

作者信息

  • 1. 温州医科大学附属第二医院神经内科,浙江 温州 325200
  • 2. 温州医科大学附属第二医院重症监护室,浙江 温州 325200
  • 3. 温州医科大学附属第二医院脑外科,浙江 温州 325200
  • 折叠

摘要

Abstract

Objective To observe the clinical efficacy and safety of ozagrel sodium injection combined with mild hypothermia in the treatment of craniocerebral injury acute cerebral infarction.Methods Sixty-two patients of craniocerebral injury acute cerebral infarction were randomly divided into control group (n =31 cases) and treatment group (n =31 cases).Control group was given Xueshuantong injection 10 mL qd,intravenous drip.Treatment group was taken with ozagrel sodium 100 mL bid,intravenous drip,and mild hypothermia treatment.Two groups were treated for 14 d.The clinical efficacy,national institutes of health stroke scale (NIHSS) scores,Barthel index (BI),changes of hemodynamic indexes and adverse drug reactions were compared between two groups.Results After treatment,the total effective rates in treatment and control groups were 90.32% (28 cases/31 cases) and 61.29% (19 cases/ 31 cases) with significant difference (P <0.05).After treatment,the main indexes in treatment and control groups were compared:NIHSS scores were (8.24 ± 0.76),(15.42 ± 1.65) points;BI were (75.23 ± 3.48),(52.32 ± 3.33) points;whole blood high shear viscosity respectively were (3.46 ±0.21),(4.63 ±0.26) mPa · s;whole blood low shear viscosity were (7.69 ±0.32),(8.38 ±0.31) mPa · s;plasma viscosity were (1.24 ±0.11),(1.76 ±0.16) mPa · s;fibrinogen were (3.07 ±0.41),(4.16 ±0.18)g · L-1,there were statistically significant differences (all P <0.05).No adverse drug reactions were observed during the treatment in two groups.Conclusion Ozagrel sodium injection combined with mild hypothermia has a definitive clinical efficacy and safety in the treatment of craniocerebral injury acute cerebral infarction,which can improve the patient's hemodynamic parameters,neurological function and activities of daily living.

关键词

奥扎格雷钠注射液/亚低温治疗/颅脑外伤/急性脑梗死/安全性

Key words

ozagrel sodium injection/mild hypothermia/craniocerebral injury/acute cerebral infarction/safety

分类

医药卫生

引用本文复制引用

陈松芳,邹明,何志勇,胡蓓蕾,郭献阳,盛汉松..奥扎格雷钠注射液联合亚低温治疗颅脑外伤急性脑梗死的临床研究[J].中国临床药理学杂志,2018,34(3):206-208,3.

基金项目

温州市科技计划基金资助项目(Y20100291) (Y20100291)

中国临床药理学杂志

OA北大核心CSCDCSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文